Prostate Cancer

The Pharmacy Times® Prostate Cancer Resource Center is a comprehensive resource for clinical news and expert insights on issues related to cancer that occurs in the prostate.

Latest News

Darolutamide Approved by FDA for Metastatic Castration-Sensitive Prostate Cancer
Darolutamide Approved by FDA for Metastatic Castration-Sensitive Prostate Cancer

June 3rd 2025

The FDA has approved darolutamide for patients with metastatic castration-sensitive prostate cancer after positive results in the ARANOTE clinical trial.

Prostate disease and treatment. Male reproductive system anatomical model in doctors hands close-up during consultation of male patient with suspected bacterial prostatitis - Image credit: Peakstock | stock.adobe.com
Anti-Diabetic Drug Could Offer New Treatment for Prostate Cancer

May 20th 2025

Prostate cancer cells dividing | Image Credit: © PRB ARTS - stock.adobe.com
ASCO GU: ARANOTE and ARASENS Trials Reinforce Darolutamide in Metastatic Hormone-Sensitive Prostate Cancer

February 26th 2025

A urologist sees male patients. They specialize in men's health issues, including prostate problems - Image credit: ImageKing | stock.adobe.com
FDA Grants Fast Track Designation to 67Cu-SAR-bisPSMA for Prostate Cancer

February 20th 2025

Male patient receiving consultation from health care professional -- Image credit: Chinnapong | stock.adobe.com
Advancements in the Management of Nonmetastatic Castrate-Resistant Prostate Cancer: A Review of Second-Generation Antiandrogens

February 19th 2025

Latest CME Events & Activities

The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmac...

2.0 Credits / Human Trafficking, Law

View More

Ensuring Pharmacy Technicians’ Proficiency in Risk Evaluation and Mitigation Strategies

1.0 Credit / Law, Pain Management, Opioids

View More

<12345